Sebastian-Valles, F.; Bernaldo Madrid, B.; Sager, C.; Carrillo López, E.; Mera Carreiro, S.; Ávila Antón, L.; García, N.S.-M.; Sampedro-Nuñez, M.A.; Díaz Pérez, J.Á.; Marazuela, M.
Chronic Treatment with Somatostatin Analogues in Recurrent Type 1 Gastric Neuroendocrine Tumors. Biomedicines 2023, 11, 872.
https://doi.org/10.3390/biomedicines11030872
AMA Style
Sebastian-Valles F, Bernaldo Madrid B, Sager C, Carrillo López E, Mera Carreiro S, Ávila Antón L, García NS-M, Sampedro-Nuñez MA, Díaz Pérez JÁ, Marazuela M.
Chronic Treatment with Somatostatin Analogues in Recurrent Type 1 Gastric Neuroendocrine Tumors. Biomedicines. 2023; 11(3):872.
https://doi.org/10.3390/biomedicines11030872
Chicago/Turabian Style
Sebastian-Valles, Fernando, Blanca Bernaldo Madrid, Carolina Sager, Elena Carrillo López, Sara Mera Carreiro, Laura Ávila Antón, Noelia Sánchez-Maroto García, Miguel Antonio Sampedro-Nuñez, Jose Ángel Díaz Pérez, and Mónica Marazuela.
2023. "Chronic Treatment with Somatostatin Analogues in Recurrent Type 1 Gastric Neuroendocrine Tumors" Biomedicines 11, no. 3: 872.
https://doi.org/10.3390/biomedicines11030872
APA Style
Sebastian-Valles, F., Bernaldo Madrid, B., Sager, C., Carrillo López, E., Mera Carreiro, S., Ávila Antón, L., García, N. S.-M., Sampedro-Nuñez, M. A., Díaz Pérez, J. Á., & Marazuela, M.
(2023). Chronic Treatment with Somatostatin Analogues in Recurrent Type 1 Gastric Neuroendocrine Tumors. Biomedicines, 11(3), 872.
https://doi.org/10.3390/biomedicines11030872